367 related articles for article (PubMed ID: 2193120)
1. Imaging with indium111-labeled anticarcinoembryonic antigen monoclonal antibody ZCE-025 of recurrent colorectal or carcinoembryonic antigen-producing cancer in patients with rising serum carcinoembryonic antigen levels and occult metastases.
Patt YZ; Lamki LM; Shanken J; Jessup JM; Charnsangavej C; Ajani JA; Levin B; Merchant B; Halverson C; Murray JL
J Clin Oncol; 1990 Jul; 8(7):1246-54. PubMed ID: 2193120
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibody imaging in patients with colorectal cancer and increasing levels of serum carcinoembryonic antigen. Experience with ZCE-025 and IMMU-4 monoclonal antibodies and proposed directions for clinical trials.
Patt YZ; Podoloff DA; Curley S; Smith R; Badkhamkar VA; Lamki LM; Jessup MM; Hohn DC
Cancer; 1993 Jun; 71(12 Suppl):4293-7. PubMed ID: 8389662
[TBL] [Abstract][Full Text] [Related]
3. Technetium 99m-labeled IMMU-4, a monoclonal antibody against carcinoembryonic antigen, for imaging of occult recurrent colorectal cancer in patients with rising serum carcinoembryonic antigen levels.
Patt YZ; Podoloff DA; Curley S; Kasi L; Smith R; Bhadkamkar V; Charnsangavej C
J Clin Oncol; 1994 Mar; 12(3):489-95. PubMed ID: 8120546
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of primary lung cancer with indium 111 anti-carcinoembryonic antigen (type ZCE-025) monoclonal antibody scintigraphy.
Krishnamurthy S; Morris JF; Antonovic R; Ahmed A; Galey WT; Duncan C; Krishnamurthy GT
Cancer; 1990 Feb; 65(3):458-65. PubMed ID: 2297636
[TBL] [Abstract][Full Text] [Related]
5. Improved tumor localization with increasing dose of indium-111-labeled anti-carcinoembryonic antigen monoclonal antibody ZCE-025 in metastatic colorectal cancer.
Patt YZ; Lamki LM; Haynie TP; Unger MW; Rosenblum MG; Shirkhoda A; Murray JL
J Clin Oncol; 1988 Aug; 6(8):1220-30. PubMed ID: 3045263
[TBL] [Abstract][Full Text] [Related]
6. Initial clinical study of indium-111-labeled clone 110 anticarcinoembryonic antigen antibody in patients with colorectal cancer.
Griffin TW; Brill AB; Stevens S; Collins JA; Bokhari F; Bushe H; Stochl MC; Gionet M; Rusckowski M; Stroupe SD
J Clin Oncol; 1991 Apr; 9(4):631-40. PubMed ID: 2066759
[TBL] [Abstract][Full Text] [Related]
7. Indium 111 ZCE-025 immunoscintigraphy in occult recurrent colorectal cancer with elevated carcinoembryonic antigen level.
Doerr RJ; Abdel-Nabi H; Merchant B
Arch Surg; 1990 Feb; 125(2):226-9. PubMed ID: 2302062
[TBL] [Abstract][Full Text] [Related]
8. Colorectal tumors: scintigraphy with In-111 anti-CEA monoclonal antibody and correlation with surgical, histopathologic, and immunohistochemical findings.
Abdel-Nabi HH; Schwartz AN; Goldfogel G; Ortman-Nabi JA; Matsuoka DM; Unger MW; Wechter DG
Radiology; 1988 Mar; 166(3):747-52. PubMed ID: 3277244
[TBL] [Abstract][Full Text] [Related]
9. Radioimmune localization of occult carcinoma.
Duda RB; Zimmer AM; Rosen ST; Gilyon KA; Webber D; Spies S; Spies W; Merchant B
Arch Surg; 1990 Jul; 125(7):866-70. PubMed ID: 2369311
[TBL] [Abstract][Full Text] [Related]
10. [Immunoscintigraphy of colorectal cancer with 111In labeled anti-CEA monoclonal antibody (ZCE-025)].
Katayama M; Nakamura K; Hashimoto T; Tsukatani Y; Fujii H; Hashimoto J; Kubo A; Hashimoto S; Teramoto T; Kodaira S
Kaku Igaku; 1991 Sep; 28(9):1057-65. PubMed ID: 1770658
[TBL] [Abstract][Full Text] [Related]
11. Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patients.
Wong JY; Chu DZ; Yamauchi D; Odom-Maryon TL; Williams LE; Liu A; Esteban JM; Wu AM; Primus FJ; Beatty JD; Shively JE; Raubitschek AA
J Nucl Med; 1998 Dec; 39(12):2097-104. PubMed ID: 9867150
[TBL] [Abstract][Full Text] [Related]
12. Radioimmunodetection of occult carcinoembryonic antigen-producing cancer.
Haseman MK; Brown DW; Keeling CA; Reed NL
J Nucl Med; 1992 Oct; 33(10):1750-6. PubMed ID: 1403140
[TBL] [Abstract][Full Text] [Related]
13. 111In-CYT-103 scanning in recurrent colorectal cancer--does it affect standard management?
Dominguez JM; Wolff BG; Nelson H; Forstrom LA; Mullan BP
Dis Colon Rectum; 1996 May; 39(5):514-9. PubMed ID: 8620800
[TBL] [Abstract][Full Text] [Related]
14. In-111 CYT-103 monoclonal antibody imaging in patients with suspected recurrent colorectal cancer.
Doerr RJ; Herrera L; Abdel-Nabi H
Cancer; 1993 Jun; 71(12 Suppl):4241-7. PubMed ID: 8508386
[TBL] [Abstract][Full Text] [Related]
15. 99Tcm-IMMU4 imaging in recurrent colorectal cancer: efficacy and impact on surgical management.
Sirisriro R; Podoloff DA; Patt YZ; Curley SA; Kasi LP; Bhadkamkar VA; Kim EE; Murray JL; Smith R; Haynie TP
Nucl Med Commun; 1996 Jul; 17(7):568-76. PubMed ID: 8843115
[TBL] [Abstract][Full Text] [Related]
16. Detection of colorectal carcinoma by anti-CEA monoclonal antibody (IOR-CEA1) labeled with 99mTc scintigraphy.
Sirisriro R; Boonkitticharoen V; Kraiphibul P; Ratanatharathorn V; Sumboonnanon K; Kanjanapitak A; Kuhapremma T; Sritara C; Puchinda D; Chouplywech P; Jalayondeja V; Pekanan P; Rochanawutanon M; Intaramarn C; Ayudhya AN; Chokesuwathana P
Hepatogastroenterology; 2000; 47(32):405-13. PubMed ID: 10791201
[TBL] [Abstract][Full Text] [Related]
17. Colorectal carcinoma: detection with indium-111 anticarcinoembryonic-antigen monoclonal antibody ZCE-025.
Abdel-Nabi HH; Schwartz AN; Higano CS; Wechter DG; Unger MW
Radiology; 1987 Sep; 164(3):617-21. PubMed ID: 3303117
[TBL] [Abstract][Full Text] [Related]
18. Contribution of SPECT to imaging of gastrointestinal adenocarcinoma with 111In-labeled anti-CEA monoclonal antibody.
Kramer EL; Sanger JJ; Walsh C; Kanamuller H; Unger MW; Halverson C
AJR Am J Roentgenol; 1988 Oct; 151(4):697-703. PubMed ID: 3048063
[TBL] [Abstract][Full Text] [Related]
19. Indium-labeled anti-colorectal carcinoma monoclonal antibody accumulation in non-tumored tissue in patients with colorectal carcinoma.
Abdel-Nabi HH; Chan HW; Doerr RJ
J Nucl Med; 1990 Dec; 31(12):1975-9. PubMed ID: 2266396
[TBL] [Abstract][Full Text] [Related]
20. Histological correlation of 17 prospective immunoscintigraphies of recurrences of colorectal carcinomas using indium-111-labeled anti-cea and(or) 19-9 monoclonal antibodies.
Chetanneau A; Lehur PA; Ripoche D; Peltier P; Saccavini JC; Vuillez JP; Tournemaine N; Thedrez P; Chatal JF
Eur J Nucl Med; 1989; 15(6):302-6. PubMed ID: 2670570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
